These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 29571422)

  • 21. The effect of pharmacological therapy on the cardiovascular system of patients with systemic rheumatic diseases.
    Atzeni F; Turiel M; Caporali R; Cavagna L; Tomasoni L; Sitia S; Sarzi-Puttini P
    Autoimmun Rev; 2010 Oct; 9(12):835-9. PubMed ID: 20678592
    [TBL] [Abstract][Full Text] [Related]  

  • 22. How early in the course of rheumatoid arthritis does the excess cardiovascular risk appear?
    Kerola AM; Kauppi MJ; Kerola T; Nieminen TV
    Ann Rheum Dis; 2012 Oct; 71(10):1606-15. PubMed ID: 22736093
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiovascular morbidity and mortality in rheumatoid arthritis.
    Gabriel SE
    Am J Med; 2008 Oct; 121(10 Suppl 1):S9-14. PubMed ID: 18926169
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Health care and burden of illness in systemic lupus erythematosus compared to rheumatoid arthritis: results from the National Database of the German Collaborative Arthritis Centres.
    Zink A; Fischer-Betz R; Thiele K; Listing J; Huscher D; Gromnica-Ihle E; Specker C; Schneider M;
    Lupus; 2004; 13(7):529-36. PubMed ID: 15352425
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic role of coronary calcification in patients with rheumatoid arthritis and systemic lupus erythematosus.
    Yiu KH; Mok MY; Wang S; Ooi GC; Khong PL; Lau CS; Tse HF
    Clin Exp Rheumatol; 2012; 30(3):345-50. PubMed ID: 22409930
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiovascular disease risk burden in primary Sjögren's syndrome: results of a population-based multicentre cohort study.
    Bartoloni E; Baldini C; Schillaci G; Quartuccio L; Priori R; Carubbi F; Bini V; Alunno A; Bombardieri S; De Vita S; Valesini G; Giacomelli R; Gerli R
    J Intern Med; 2015 Aug; 278(2):185-92. PubMed ID: 25582881
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiovascular events in systemic lupus erythematosus and rheumatoid arthritis : emerging concepts, early diagnosis and management.
    Chogle AR; Chakravarty A
    J Assoc Physicians India; 2007 Jan; 55():32-40. PubMed ID: 17444342
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Atherosclerosis in systemic lupus erythematosus].
    Tazi Mezalek Z; Harmouche H; Ammouri W; Maamar M; Adnaoui M; Cacoub P
    Presse Med; 2014 Oct; 43(10 Pt 1):1034-47. PubMed ID: 25201598
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Do cardiovascular risk factors confer the same risk for cardiovascular outcomes in rheumatoid arthritis patients as in non-rheumatoid arthritis patients?
    Gonzalez A; Maradit Kremers H; Crowson CS; Ballman KV; Roger VL; Jacobsen SJ; O'Fallon WM; Gabriel SE
    Ann Rheum Dis; 2008 Jan; 67(1):64-9. PubMed ID: 17517756
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prospective risk of rheumatologic disease associated with occupational exposure in a cohort of male construction workers.
    Blanc PD; Järvholm B; Torén K
    Am J Med; 2015 Oct; 128(10):1094-101. PubMed ID: 26007670
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cardiovascular risk in autoimmune and inflammatory disorders].
    Peeters MA; Chizzolini C
    Rev Med Suisse; 2011 Apr; 7(291):867-71. PubMed ID: 21598728
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atherosclerotic cardiovascular disease in hospitalized patients with systemic sclerosis: higher mortality than patients with lupus and rheumatoid arthritis.
    Dave AJ; Fiorentino D; Lingala B; Krishnan E; Chung L
    Arthritis Care Res (Hoboken); 2014 Feb; 66(2):323-7. PubMed ID: 24022876
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Subclinical atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus.
    Salmon JE; Roman MJ
    Am J Med; 2008 Oct; 121(10 Suppl 1):S3-8. PubMed ID: 18926167
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiovascular involvement in systemic autoimmune diseases.
    Sitia S; Atzeni F; Sarzi-Puttini P; Di Bello V; Tomasoni L; Delfino L; Antonini-Canterin F; Di Salvo G; De Gennaro Colonna V; La Carrubba S; Carerj S; Turiel M
    Autoimmun Rev; 2009 Feb; 8(4):281-6. PubMed ID: 18817899
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence of systemic inflammation and estimation of coronary artery disease risk: a population perspective.
    Wilson PW
    Am J Med; 2008 Oct; 121(10 Suppl 1):S15-20. PubMed ID: 18926165
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunotherapeutic Biologic Agents in Autoimmune and Autoinflammatory Diseases.
    Ostrov BE
    Immunol Invest; 2015; 44(8):777-802. PubMed ID: 26575464
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiovascular disease in systemic sclerosis.
    Cannarile F; Valentini V; Mirabelli G; Alunno A; Terenzi R; Luccioli F; Gerli R; Bartoloni E
    Ann Transl Med; 2015 Jan; 3(1):8. PubMed ID: 25705640
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Performance of traditional risk factors in identifying a higher than expected coronary atherosclerotic burden.
    Dores H; de Araújo Gonçalves P; Ferreira AM; Carvalho MS; Sousa PJ; Cardim N; Marques H; Pereira Machado F
    Rev Port Cardiol; 2015 Apr; 34(4):247-53. PubMed ID: 25843312
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypertension and Cardiovascular Outcomes in Inflammatory and Autoimmune Diseases: A Systematic Review and Meta-analysis.
    Barozet M; Le Tilly O; Bejan-Angoulvant T; Fesler P; Roubille C
    Curr Hypertens Rep; 2024 May; ():. PubMed ID: 38819751
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endothelial activation, endothelial dysfunction and premature atherosclerosis in systemic autoimmune diseases.
    Bijl M
    Neth J Med; 2003 Sep; 61(9):273-7. PubMed ID: 14692439
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.